Mouse Anti-APOL1 Recombinant Antibody (CBT4221) (V2LY-0625-LY2255)

Berrigan, M., Austrie, J., Fleishman, A., Tercyak, K. P., Pollak, M. R., Pavlakis, M., ... & Rodrigue, J. R. (2021). Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation. American Journal of Transplantation, 21(3), 1197-1205.

Scales, S. J., Gupta, N., De Mazière, A. M., Posthuma, G., Chiu, C. P., Pierce, A. A., ... & Peterson, A. S. (2020). Apolipoprotein L1-specific antibodies detect endogenous APOL1 inside the endoplasmic reticulum and on the plasma membrane of podocytes. Journal of the American Society of Nephrology, 31(9), 2044-2064.

Gordon, E. J., Wicklund, C., Lee, J., Sharp, R. R., & Friedewald, J. (2019). A national survey of transplant surgeons and nephrologists on implementing apolipoprotein L1 (APOL1) genetic testing into clinical practice. Progress in Transplantation, 29(1), 26-35.

Lannon, H., Shah, S. S., Dias, L., Blackler, D., Alper, S. L., Pollak, M. R., & Friedman, D. J. (2019). Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney international, 96(6), 1303-1307.

Young, B. A., Blacksher, E., Cavanaugh, K. L., Freedman, B. I., Fullerton, S. M., Kopp, J. B., ... & Burke, W. (2019). Apolipoprotein L1 testing in African Americans: involving the community in policy discussions. American journal of nephrology, 50(4), 303-311.

Kumar, V., Ayasolla, K., Jha, A., Mishra, A., Vashistha, H., Lan, X., ... & Singhal, P. C. (2019). Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu. American Journal of Physiology-Cell Physiology, 317(2), C209-C225.

Freedman, B. I., Limou, S., Ma, L., & Kopp, J. B. (2018). APOL1-associated nephropathy: a key contributor to racial disparities in CKD. American Journal of Kidney Diseases, 72(5), S8-S16.

Kumar, V., Vashistha, H., Lan, X., Chandel, N., Ayasolla, K., Shoshtari, S. S. M., ... & Singhal, P. C. (2018). Role of apolipoprotein L1 in human parietal epithelial cell transition. The American journal of pathology, 188(11), 2508-2528.

Nadkarni, G. N., Galarneau, G., Ellis, S. B., Nadukuru, R., Zhang, J., Scott, S. A., ... & Bottinger, E. P. (2017). Apolipoprotein L1 variants and blood pressure traits in African Americans. Journal of the American College of Cardiology, 69(12), 1564-1574.

Bruno, J., Pozzi, N., Oliva, J., & Edwards, J. C. (2017). Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles. Journal of Biological Chemistry, 292(44), 18344-18353.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols